DNA methylation and histone modifications can regulate synaptopodin expression, and thus, hypermethylation of the SYNPO promoter has been observed in diabetic nephropathy, leading to reduced synaptopodin levels and podocyte injury (54). Here, SYNPO is linked to diabetic kidney disease.